Makula-App

Die neue Makula-App des AMD-Netz steht ab sofort kostenlos zum Download im App Store und im Google Play Store zur Verfügung.

Teaserbild Leben mit AMD - Ausführliche Bildbeschreibung verfügbar unter: https://www.amd-netz.de/bildbeschreibung.php?b=206

Literatur zur Erkrankung AMD

  1. Agarwal A, Aggarwal K, Gupta V. Management of neovascular age-related macular degeneration: A review on landmark randomized controlled trials. Middle East Afr J Ophthalmol 2016;23(1):27–37; doi: 10.4103/0974-92
  2. Amsler M. Die Untersuchung des qualitativen Sehens mit dem quadratischen Netz. Anweisung zum Gebrauch der Testtafeln. Theodore Hamblin LTD, 1958
  3. Armstrong RA, Mousavi M. Overview of risk factors for age-related macular degeneration (AMD). J Stem Cells 2015;10(3):171–91
  4. Ashraf M, Souka AAR. Aflibercept in age-related macular degeneration: evaluating its role as a primary therapeutic option. Eye (Lond) 2017;31(11):1523–36; doi: 10.1038/eye2017.81
  5. Bhisitkul RB, Desai SJ, Boyer DS, Sadda SR, Zhang K. Fellow eye comparisons for 7-year outcomes in ranibizumab-treated AMD subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP study). Ophthalmology 2016;123(6):1269–77; doi: 10.1016/j.ophtha.2016.01.033
  6. Brandl C, Stark KJ, Wintergerst M, Heinemann M, Heid IM, Finger RP. Epidemiology of age-related macular degeneration. Ophthalmologe 2016;113(9):735–45; doi: 10.1007/s00347-016-0341-6
  7. BVA, DOG. Leitlinie Nr. 7, Versorgung von Seh­be­hin­der­ten und Blinden. Stand: August 2011
  8. BVA, DOG. Leitlinie Nr. 21, Alters­abhängige Makula­degeneration AMD. Stand: 30. Oktober 2015
  9. BVA, DOG, RG. Stellungnahme des Berufs­ver­ban­des der Augenärzte Deutschlands, der Deutschen Ophthal­molo­gischen Gesellschaft und der Reti­no­lo­gi­schen Gesellschaft: OCT-Angiographie in Deutschland: Präsentation, Nomenklatur und Zukunfts­wünsche. Stand: Januar 2017.
  10. BVA, RG, DOG. Stellungnahme von DOG, Reti­no­lo­gi­scher Gesellschaft und BVA. Die Anti-VEGF-Therapie bei der neo­vas­ku­lä­ren alter­sabhängigen Makula­degeneration: The­ra­peu­ti­sche Strategien. Stand: November 2014
  11. BVA, RG, DOG. Stellungnahme des Berufs­ver­ban­des der Augenärzte Deutschlands, der Deutschen Ophthal­molo­gischen Gesellschaft und der Reti­no­lo­gi­schen Gesellschaft: Lasertherapie von Drusen bei alters­abhän­giger Makula­degeneration. Stand: August 2017
  12. Casten RJ, Rovner BW. Depression in age-related macular degeneration. J Vis Impairment Blindness 2008;102(10):591–9
  13. Crews JE, Campbell VA. Vision impairment and hearing loss among community-dwelling older Americans: implications for health and functioning. Am J Pub Health 2004;94(5):823–9
  14. DOG, RG, BVA. Aktuelle Stellungnahme der Deutschen Ophthal­molo­gischen Gesellschaft, der Reti­no­lo­gi­schen Gesellschaft und des Berufs­ver­ban­des der Augenärzte Deutschlands zu Nahrungs­ergänzungs­mitteln bei alters­abhän­giger Makula­degeneration. Stand: Oktober 2014
  15. Ferris FL, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, Sadda SR, Beckman Initiative for Macular Research Clas­si­fi­ca­tion Committee. Clinical clas­si­fi­ca­tion of age-related macular degeneration. Ophthalmology 2013;120(4):844–51; doi: 10.1016/j.ophtha.2012.10.036
  16. Framme C, Korobelnik J, Finger R, Kodjikian L. Impact of treatment interval in naïve nAMD patients: 12-month results of the PERSEUS and RAINBOW studies. Ophthalmology Retina2017; in press
  17. Herrmann P, Holz FG, Charbel Issa P. Ätiologie und Pathogenese der alter­sabhängigen Makula­degeneration. Ophthalmologe 2013;110(4):377–89
  18. Jiao NJ. [Observation on therapeutic effect of age-related macular degeneration treated with acupuncture]. Zhongguo Zhen Jiu 2011;31(1):43–5
  19. Li G, Shao Y, Yin J.[Early age-related macular degeneration treated with emayaoling acupuncture technique: a randomized controlled trial]. Zhongguo Zhen Jiu 2017;37(12):1294–8; doi: 10.13703/j.0255-2930.2017.12.011
  20. Lim LS, Mitchell P, Seddon JM et al. Age-related macular degeneration. Lancet 2012;379:1728–38
  21. Lövdén M, Ghisletta P, Lindenberger U. Social participation attenuates decline in perceptual speed in old and very old age. Psychology Aging 2005;20(3):423–34leitlinie
  22. Mares JA, Voland R, Sondel SA, Millen AE, LaRowe T, Moeller SM, Klein ML, Blodi BA, Chappell R, Tinker L, Ritenbaugh C, Gehrs K, Sarto G, Johnson EJ, Snodderly M, Wallace RB. Healthy lifestyles related to subsequent prevalence of age-related macular degeneration. Arch Ophthalmol 2011;129(4):470–80; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3075357/
  23. McCannel CA. Meta-analysis of endo­ph­thal­mi­tis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina 2011;31(4):654–61; doi: 10.1097/IAE.0b013e31820a67e4
  24. McGuinness MB, Le J, Mitchell P, Gopinath B, Cerin E, Saskens NTM, Schick T, Hoyng CB, Guymer RH, Finger RP. Physical activity and age-related macular degeneration: a systematic literature review and meta-analysis. Am J Ophthalmol 2017;180:29–38; doi: https://doi.org/10.1016/j.ajo.2017.05.016
  25. Myers CE, Klein BE, Gangnon R et al. Cigarette smoking and the natural history of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 2014;121:1949‒55
  26. Nilsson UL, Frennesson C, Nilsson SE. Patients with AMD and a large absolute central scotoma can be trained successfully to use eccentric viewing, as demonstrated in a scanning laser oph­thal­mos­cope. Vision Res 2003;43(16):1777–87
  27. Palmer S, Logan D, Nabili S, Dutton GN. Effective reha­bi­li­ta­tion of reading by training in the technique of eccentric viewing: evaluation of a 4-year programme of service delivery. Br J Ophthalmol 2010;94(4):494–7; doi: 10.1136/bjo.2008.152231. Epub Oct 12 2009
  28. Rofagha S, Bhisitkul RB, Boyer DS, Sadda SR, Zhang K, SEVEN-UP Study Group. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). Ophthalmology 2013;120(11):2292–9; doi: 10.1016/j.ophtha.2013.03.046
  29. Rovner BW et al. Activity loss is associated with cognitive decline in age-related macular degeneration. Alzheimer's Dementia 2009;5(1):12–7
  30. Schmidl D, Garhöfer G, Schmetterer L. Nutritional supplements in age-related macular degeneration. Acta Ophthalmol 2015;93(2):105–21; doi: 10.1111/aos.12650
  31. Rufai SR, Almuhtaseb H, Paul RM, Stuart BL, Kendrick T, Lee H, Lotery AJ. A systematic review to assess the ‚treat-and-extend‘ dosing regimen for neovascular age-related macular degeneration using ranibizumab. Eye (Lond) 2017;31(9):1337–44; doi: 10.1038/eye.2017.67
  32. Sarwar S, Clearfield E, Soliman MK, Sadiq MA, Baldwin AJ, Hanout M, Agarwal A, Sepah YJ, Do DV, Nguyen QD. Aflibercept for neovascular age-related macular degeneration. Cochrane Database Syst Rev 2016;2:CD011346; doi: 10.1002/14651858.CD
  33. Singh N, Srinivasan S, Muralidharan V, Roy R, V J, Raman R. Prevention of age-related macular degeneration. Asia Pac J Ophthalmol (Phila) 2017;6(6):520–6; doi: 10.22608/APO.2017416
  34. Taylor DJ, Smith ND, Binns AM, Crabb DP. The effect of non-neovascular age-related macular degeneration on face recognition performance. Graefes Arch Clin Exp Ophthalmol 2018;256(4):815–21; doi: 10.1007/s00417-017-3879-3
  35. Wahl HW, Heyl V, Langer N. Quality of life by limited vision in old age: the example of age-related macular degeneration. Ophthalmologe 2008;105(8):735–43; doi: 10.1007/s00347-008-1724-0
  36. Wallhagen MI, Strawbridge WJ, Shema SJ, Kurata J, Kaplan GA. Comparative impact of hearing and vision impairment on subsequent functioning. J Am Geriatr Soc 2001;49(8):1086–92
  37. Welte AK, Hahn U, Büssing A, Krummenauer F. [Systematic review of the application of complementary and alternative medicine and their potential therapeutic benefits in the treatment of ophthalmology patients]. Klin Monbl Augenheilkd 2017;234(5):686–96; doi: 10.1055/s-0042-106901
  38. Zhang Y, Chioresco C, Schweizer ML, Abràmoff MD. Effects of aflibercept for neovascular age-related macular degeneration: A systematic review and meta-analysis of observational comparative studies. Invest Ophthalmol Vis Sci 2017;58(13):5616–27; doi: 10.1167/iovs.17

Literatur zu den Risi­ko­fak­to­ren Bluthochdruck und Herz-Kreis­lau­f­er­kran­kun­gen

  1. Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, Buggage R, Pleil A, Mitchell P., Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis., BMC Ophthalmol. 2010 Dec 13;10:31. doi: 10.1186/1471-2415-10-31. Review.
  2. Joslin CE, Vajaranant TS, Ulanski LJ 2nd, Age-Related Macular Degeneration and Mortality in the Age-Related Eye Disease Study (AREDS): The Effect of Sex and Time, Ophthalmol Retina. 2017 Jan - Feb;1(1):49-58. doi: 10.1016/j.oret.2016.09.004. Epub 2016 Nov 18.
  3. Chen X, Rong SS, Xu Q, Tang FY, Liu Y, Gu H, Tam PO, Chen LJ, Brelén ME, Pang CP, Zhao C, Diabetes mellitus and risk of age-related macular degeneration: a systematic review and meta-analysis, PLoS One. 2014 Sep 19;9(9):e108196. doi: 10.1371/journal.pone.0108196. eCollection 2014. Review.